Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0092 | 0.1305 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0569 | 0.8565 | 0.8629 |
Toxoplasma gondii | peptidyl-prolyl cis-trans isomerase, FKBP-type domain-containing protein | 0.0091 | 0.1287 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0091 | 0.1287 | 0.1297 |
Loa Loa (eye worm) | FKBP-type peptidyl-prolyl cis-trans isomerase-30 | 0.0091 | 0.1287 | 0.1297 |
Trichomonas vaginalis | peptidylprolyl isomerase, putative | 0.0659 | 0.9926 | 1 |
Leishmania major | fk506-binding protein 1-like protein | 0.0659 | 0.9926 | 1 |
Toxoplasma gondii | peptidyl-prolyl cis-trans isomerase, FKBP-type domain-containing protein | 0.0091 | 0.1287 | 0.5 |
Leishmania major | peptidyl-prolyl cis-trans isomerase, putative | 0.0091 | 0.1287 | 0.1297 |
Treponema pallidum | peptidyl-prolyl cis-trans isomerase, FKBP-type, 22 kDa (fklB) | 0.0659 | 0.9926 | 1 |
Trichomonas vaginalis | fk506-binding protein, putative | 0.0091 | 0.1287 | 0.1297 |
Loa Loa (eye worm) | FKBP5 protein | 0.0659 | 0.9926 | 1 |
Loa Loa (eye worm) | FKBP-type peptidyl-prolyl cis-trans isomerase-33 | 0.0091 | 0.1287 | 0.1297 |
Schistosoma mansoni | hypothetical protein | 0.0091 | 0.1287 | 0.1287 |
Brugia malayi | FKBP-type peptidyl-prolyl cis-trans isomerase-59, BmFKBP59 | 0.066 | 0.9944 | 1 |
Echinococcus granulosus | FK506 binding protein 8 38 kDa | 0.0091 | 0.1287 | 0.1287 |
Trichomonas vaginalis | fk506-binding protein, putative | 0.0091 | 0.1287 | 0.1297 |
Entamoeba histolytica | peptidyl-prolyl cis-trans isomerase, FKBP-type, putative | 0.0663 | 1 | 1 |
Schistosoma mansoni | immunophilin FK506 binding protein FKBP12 | 0.0659 | 0.9926 | 0.9926 |
Mycobacterium leprae | PROBABLE TRIGGER FACTOR (TF) PROTEIN TIG | 0.0091 | 0.1287 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0006 | 0.0000069562 | 0.0000070079 |
Loa Loa (eye worm) | FKBP-type peptidyl-prolyl cis-trans isomerase-13 | 0.0091 | 0.1287 | 0.1297 |
Trichomonas vaginalis | immunophilin, putative | 0.0659 | 0.9926 | 1 |
Schistosoma mansoni | immunophilin | 0.0573 | 0.8621 | 0.8621 |
Loa Loa (eye worm) | FKBP-type peptidyl-prolyl cis-trans isomerase-12 | 0.0659 | 0.9926 | 1 |
Trypanosoma brucei | peptidyl-prolyl cis-trans isomerase, putative | 0.0659 | 0.9926 | 1 |
Wolbachia endosymbiont of Brugia malayi | FKBP-type peptidylprolyl isomerase | 0.0091 | 0.1287 | 0.5 |
Mycobacterium ulcerans | FK-506 binding protein, peptidyl-prolyl cis-trans isomerase | 0.0659 | 0.9926 | 1 |
Trypanosoma brucei | FKBP-type peptidylprolyl cis-trans isomerase, putative | 0.0091 | 0.1287 | 0.1297 |
Giardia lamblia | 70 kDa peptidylprolyl isomerase, putative | 0.0659 | 0.9926 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.1287 | 0.1297 |
Leishmania major | FKBP-type peptidyl-prolyl cis-trans isomerase, putative | 0.0091 | 0.1287 | 0.1297 |
Trichomonas vaginalis | fk506-binding protein, putative | 0.0659 | 0.9926 | 1 |
Echinococcus multilocularis | 0.0091 | 0.1287 | 0.1287 | |
Wolbachia endosymbiont of Brugia malayi | FKBP-type peptidylprolyl isomerase | 0.0091 | 0.1287 | 0.5 |
Onchocerca volvulus | 0.0091 | 0.1287 | 0.9866 | |
Plasmodium falciparum | peptidyl-prolyl cis-trans isomerase FKBP35 | 0.0659 | 0.9926 | 1 |
Trypanosoma brucei | FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative | 0.0659 | 0.9926 | 1 |
Trypanosoma cruzi | FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative | 0.0659 | 0.9926 | 1 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase, putative | 0.0659 | 0.9926 | 1 |
Entamoeba histolytica | peptidyl-prolyl cis-trans isomerase, FKBP-type , putative | 0.0663 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0091 | 0.1287 | 0.1297 |
Chlamydia trachomatis | peptidyl-prolyl cis-trans isomerase | 0.0091 | 0.1287 | 0.5 |
Leishmania major | peptidylprolyl isomerase-like protein | 0.0659 | 0.9926 | 1 |
Giardia lamblia | FKBP-type peptidyl-prolyl cis-trans isomerase | 0.0659 | 0.9926 | 1 |
Trichomonas vaginalis | fk506 binding protein, putative | 0.0091 | 0.1287 | 0.1297 |
Toxoplasma gondii | peptidyl-prolyl cis-trans isomerase, FKBP-type domain-containing protein | 0.0091 | 0.1287 | 0.5 |
Brugia malayi | FKBP-type peptidyl-prolyl cis-trans isomerase-12, BmFKBP-12 | 0.0659 | 0.9926 | 0.998 |
Toxoplasma gondii | peptidyl-prolyl isomerase FKBP12, putative | 0.0091 | 0.1287 | 0.5 |
Echinococcus multilocularis | peptidyl prolyl cis trans isomerase FKBP4 | 0.0573 | 0.8621 | 0.8621 |
Echinococcus multilocularis | fk506 binding protein | 0.0659 | 0.9926 | 0.9926 |
Echinococcus granulosus | peptidyl prolyl cis trans isomerase FKBP1A | 0.0659 | 0.9926 | 0.9926 |
Echinococcus multilocularis | peptidyl prolyl cis trans isomerase FKBP4 | 0.0663 | 1 | 1 |
Leishmania major | peptidyl-prolyl cis-trans isomerase, macrophage infectivity potentiator precursor, putative | 0.0091 | 0.1287 | 0.1297 |
Trypanosoma cruzi | FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative | 0.0659 | 0.9926 | 1 |
Mycobacterium tuberculosis | Probable trigger factor (TF) protein Tig | 0.0091 | 0.1287 | 0.5 |
Schistosoma mansoni | fk506 binding protein | 0.0091 | 0.1287 | 0.1287 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase, putative | 0.0659 | 0.9926 | 1 |
Trypanosoma brucei | macrophage infectivity potentiator, precursor, putative | 0.0091 | 0.1287 | 0.1297 |
Echinococcus multilocularis | FK506 binding protein 8, 38 kDa | 0.0095 | 0.1361 | 0.1361 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0091 | 0.1287 | 0.1297 |
Echinococcus granulosus | peptidyl prolyl cis trans isomerase FKBP4 | 0.0573 | 0.8621 | 0.8621 |
Echinococcus granulosus | FK506 binding protein 2 | 0.0091 | 0.1287 | 0.1287 |
Trypanosoma brucei | peptidyl-prolyl cis-trans isomerase, putative | 0.0091 | 0.1287 | 0.1297 |
Schistosoma mansoni | immunophilin | 0.0663 | 1 | 1 |
Schistosoma mansoni | immunophilin | 0.0663 | 1 | 1 |
Plasmodium vivax | 70 kDa peptidylprolyl isomerase, putative | 0.0659 | 0.9926 | 1 |
Trichomonas vaginalis | peptidylprolyl isomerase, putative | 0.0659 | 0.9926 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.